EGFR and lung cancer: Although our findings identify IL-35 as a key immunosuppressive cytokine that impairs NK cell function in the EGFR-mutant non–small cell lung cancer (NSCLC) microenvironment, several limitations and potential confounding factors should be acknowledged to ensure proper interpretation of the results.